CHARLESTON, S.C. (WCIV) — An Isle of Palms businessman known for a high-profile property dispute is preparing to enter the race for governor of South Carolina, promising sweeping changes to how state ...
Add Yahoo as a preferred source to see more of our stories on Google. Rom Reddy announced his run for governor of South Carolina on Monday, March 16, 2026. (Photo courtesy of Rom Reddy's campaign) A ...
CHARLESTON, S.C. (WCSC) — Rom Reddy, a businessman, founder of the South Carolina branch of the Department of Government Efficiency and a seven-figure donor to President Trump, announced that he is ...
CHARLESTON, S.C. (WCBD) – Rom Reddy, a Lowcountry business owner and political activist, announced Monday that he is running for Governor of South Carolina. Reddy, founder of DOGESC and graduate of ...
Charleston, S.C. (WOLO)– A new candidate threw his name in the running for the Republican nomination governor Monday. Rom Reddy, a Charleston businessman and founder of DOGESC says he will not accept ...
Wealthy beachfront property owner Rom Reddy, who launched a statewide group called DOGE SC, has entered the governor’s race. The Isles of Palms resident announced his bid Monday, the first day of ...
COLUMBIA, S.C. (WACH) — Businessman Rom Reddy announced Monday that he is running for governor of South Carolina. Reddy, the founder of DOGESC, says his campaign will launch a seven-figure advertising ...
CHARLESTON , S.C. (WCIV) — Rom Reddy, the founder of the Elon Musk-inspired DOGESC organization who prior gained notoriety for building a seawall and fighting an ongoing years-long battle to keep it, ...
SACRAMENTO, Calif. - The United States Department of Justice says that 42-year-old Navin Khanna of Holmdel, New Jersey has pleaded guilty to multiple charges related to a nationwide theft ring ...
MUMBAI, Feb 25 (Reuters) - Indian drugmaker Dr Reddy's Laboratories (REDY.NS), opens new tab is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, ...
Dr. Reddy’s Laboratories (RDY) announced on Friday that the U.S. Food and Drug Administration has accepted for review its marketing application for a biosimilar targeting Orencia, a blockbuster ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果